These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 28056037)

  • 41. Taking promoters out of enhancers in sequence based predictions of tissue-specific mammalian enhancers.
    Herman-Izycka J; Wlasnowolski M; Wilczynski B
    BMC Med Genomics; 2017 May; 10(Suppl 1):34. PubMed ID: 28589862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
    Kang Z; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants.
    Parker SC; Stitzel ML; Taylor DL; Orozco JM; Erdos MR; Akiyama JA; van Bueren KL; Chines PS; Narisu N; ; Black BL; Visel A; Pennacchio LA; Collins FS; ;
    Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17921-6. PubMed ID: 24127591
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A model of active transcription hubs that unifies the roles of active promoters and enhancers.
    Zhu I; Song W; Ovcharenko I; Landsman D
    Nucleic Acids Res; 2021 May; 49(8):4493-4505. PubMed ID: 33872375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of genomic enhancers through spatial integration of single-cell transcriptomics and epigenomics.
    Bravo González-Blas C; Quan XJ; Duran-Romaña R; Taskiran II; Koldere D; Davie K; Christiaens V; Makhzami S; Hulselmans G; de Waegeneer M; Mauduit D; Poovathingal S; Aibar S; Aerts S
    Mol Syst Biol; 2020 May; 16(5):e9438. PubMed ID: 32431014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In silico identification of enhancers on the basis of a combination of transcription factor binding motif occurrences.
    Fang Y; Wang Y; Zhu Q; Wang J; Li G
    Sci Rep; 2016 Sep; 6():32476. PubMed ID: 27582178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrating and mining the chromatin landscape of cell-type specificity using self-organizing maps.
    Mortazavi A; Pepke S; Jansen C; Marinov GK; Ernst J; Kellis M; Hardison RC; Myers RM; Wold BJ
    Genome Res; 2013 Dec; 23(12):2136-48. PubMed ID: 24170599
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Opposite Effects of Histone H1 and HMGN5 Protein on Distant Interactions in Chromatin].
    Nizovtseva EV; Polikanov YS; Kulaeva OI; Clauvelin N; Postnikov YV; Olson WK; Studitsky VM
    Mol Biol (Mosk); 2019; 53(6):1038-1048. PubMed ID: 31876282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epigenetics of Muscle- and Brain-Specific Expression of KLHL Family Genes.
    Ehrlich KC; Baribault C; Ehrlich M
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182325
    [No Abstract]   [Full Text] [Related]  

  • 50. The histone variant H2A.Z is an important regulator of enhancer activity.
    Brunelle M; Nordell Markovits A; Rodrigue S; Lupien M; Jacques PÉ; Gévry N
    Nucleic Acids Res; 2015 Nov; 43(20):9742-56. PubMed ID: 26319018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The hyper-activation of transcriptional enhancers in breast cancer.
    Li QL; Wang DY; Ju LG; Yao J; Gao C; Lei PJ; Li LY; Zhao XL; Wu M
    Clin Epigenetics; 2019 Mar; 11(1):48. PubMed ID: 30867030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-resolution profiling of histone methylations in the human genome.
    Barski A; Cuddapah S; Cui K; Roh TY; Schones DE; Wang Z; Wei G; Chepelev I; Zhao K
    Cell; 2007 May; 129(4):823-37. PubMed ID: 17512414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential analysis of chromatin accessibility and histone modifications for predicting mouse developmental enhancers.
    Fu S; Wang Q; Moore JE; Purcaro MJ; Pratt HE; Fan K; Gu C; Jiang C; Zhu R; Kundaje A; Lu A; Weng Z
    Nucleic Acids Res; 2018 Nov; 46(21):11184-11201. PubMed ID: 30137428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancer-gene specificity in development and disease.
    Pachano T; Haro E; Rada-Iglesias A
    Development; 2022 Jun; 149(11):. PubMed ID: 35686641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EpiCompare: an online tool to define and explore genomic regions with tissue or cell type-specific epigenomic features.
    He Y; Wang T
    Bioinformatics; 2017 Oct; 33(20):3268-3275. PubMed ID: 28605501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chromatin signatures of active enhancers.
    Spicuglia S; Vanhille L
    Nucleus; 2012 Mar; 3(2):126-31. PubMed ID: 22555596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HebbPlot: an intelligent tool for learning and visualizing chromatin mark signatures.
    Girgis HZ; Velasco A; Reyes ZE
    BMC Bioinformatics; 2018 Sep; 19(1):310. PubMed ID: 30176808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genome-Wide Definition of Promoter and Enhancer Usage during Neural Induction of Human Embryonic Stem Cells.
    Poletti V; Delli Carri A; Malagoli Tagliazucchi G; Faedo A; Petiti L; Mazza EM; Peano C; De Bellis G; Bicciato S; Miccio A; Cattaneo E; Mavilio F
    PLoS One; 2015; 10(5):e0126590. PubMed ID: 25978676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A modified protocol of Capture-C allows affordable and flexible high-resolution promoter interactome analysis.
    Golov AK; Abashkin DA; Kondratyev NV; Razin SV; Gavrilov AA; Golimbet VE
    Sci Rep; 2020 Sep; 10(1):15491. PubMed ID: 32968144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chromatin accessibility dynamics across
    Jänes J; Dong Y; Schoof M; Serizay J; Appert A; Cerrato C; Woodbury C; Chen R; Gemma C; Huang N; Kissiov D; Stempor P; Steward A; Zeiser E; Sauer S; Ahringer J
    Elife; 2018 Oct; 7():. PubMed ID: 30362940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.